Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2V617F Mutation
Global Medical Genetics · 01.06.2024 · 11 (02) · 132-141
DOI: 10.1055/s-0044-1785537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Medical Genetics, erschienen am 01.06.2024. Verfasst von Yupeng Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Engineering, Southwest Jiaotong University, Chengdu, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
AbstractPrecise quantification of the JAK2V617F mutation using highly sensitive assays is crucial for diagnosis, treatment process monitoring, and prognostic prediction in myeloproliferative neoplasms' (MPNs) patients. Digital droplet polymerase chain reaction (ddPCR) enables precise quantification of low-level mutations amidst a high percentage of wild type alleles without the need for external calibrators or endogenous controls. The objective of this study was to optimize a ddPCR assay for detecting the JAK2V617F mutation and establish it as a laboratory-developed ddPCR assay in our center. The optimization process involved fine-tuning five key parameters: primer/probe sequences and concentrations, annealing temperature, template amount, and PCR cycles. Our ddPCR assay demonstrated exceptional sensitivity, and the limit of quantification (LoQ) was 0.01% variant allele frequency with a coefficient of variation of approximately 76%. A comparative analysis with quantitative PCR on 39 samples showed excellent consistency (r = 0.988).In summary, through rigorous optimization process and comprehensive analytic performance validation, we have established a highly sensitive and discriminative laboratory-developed ddPCR platform for JAK2V617F detection. This optimized assay holds promise for early detection of minimal residual disease, personalized risk stratification, and potentially more effective treatment strategies in MPN patients and non-MPN populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences and Engineering, Southwest Jiaotong University, Chengdu, China.
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Department of Hematopathololgy, Tianjin Institutes of Health Science, Tianjin, China.
- Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Zitieren
APA
Liu, Y., Han, C., Li, J., Xu, S., Xiao, Z., Guo, Z., Rao, S., & Yao, Y. (2024). Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2V617F Mutation. Global Medical Genetics, 11(02), 132-141. https://doi.org/10.1055/s-0044-1785537
Vancouver
Liu Y, Han C, Li J, Xu S, Xiao Z, Guo Z, et al. Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2V617F Mutation. Global Medical Genetics. 2024;11(02):132-141. doi:10.1055/s-0044-1785537
BibTeX
@article{Liu2024,
author = {Liu, Yupeng and Han, Cong and Li, Jie and Xu, Shicai and Xiao, Zhijian and Guo, Zhiyun and Rao, Shuquan and Yao, Yao},
title = {Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2V617F Mutation},
journal = {Global Medical Genetics},
year = {2024},
volume = {11},
number = {02},
pages = {132--141},
doi = {10.1055/s-0044-1785537}
}
EUVIMED